ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 128635 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 128635; 2) Community: the network communities that were significantly associated with the response to NSC 128635; 3) Molecule: the relationships between components within communities and NSC 128635; 4) MDR: the compounds that were significantly associated with the NSC 128635.

NSC Compound Enrichment Correlation
NSC 751042 Null 0.00485717408280859 0.13891395
NSC 113452 Null 0.00485717408280862 0.21357387
NSC 309401 2H-Pyrrolo[3,2-f]quinazoline-2,4(3H)-diamine, 3-[(3-aminophenyl)methyl]-, dihydrochloride 0.0048681766467277 0.33461795
NSC 329691 HM-4 0.0048681766467277 0.38492288
NSC 617309 Null 0.0048681766467277 0.40220505
NSC 627581 Null 0.0048681766467277 0.34822844
NSC 634037 4-amino-3-bromo-1-(.beta.-D-ribofuranosyl)pyrrolo[2,3-d] pyridazine 0.0048681766467277 0.3893412
NSC 639976 Cyclopentanone, 2-[2-methyl-2-[4-(2-methylpropyl)- phenyl]ethylidene]-5-[(4-morpholinyl)methyl]-, hydrochloride 0.0048681766467277 0.44953408
NSC 681637 Camptothecin Derivative 0.0048681766467277 0.24182576
NSC 690271 ANTINEOPLASTIC-690271 0.0048681766467277 0.32378253
Total:89  Current:15    [First] [Prev] [Next] [Last]